NICE's social value judgements about equity in health and health care

Health Economics, Policy and Law

Volumn 8, Issue 2, 2013, Pages 145-165

  Shah, Koonal K ^a,b   Cookson, Richard ^c   Culyer, Anthony J ^c,d   Littlejohns, Peter ^e  

^a OFFICE OF HEALTH ECONOMICS   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF YORK   (United Kingdom)

^d UNIVERSITY OF TORONTO   (Canada)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CISPLATIN; LENALIDOMIDE; OMALIZUMAB; PEMETREXED; SUNITINIB; TRASTUZUMAB;

ADVANCED CANCER; ALLERGIC ASTHMA; ASBESTOSIS; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RISK; COST EFFECTIVENESS ANALYSIS; DRUG COST; GASTROINTESTINAL STROMAL TUMOR; HEALTH CARE; HEALTH CARE DISPARITY; HEALTH CARE DISTRIBUTION; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE UTILIZATION; HEALTH DISPARITY; HEALTH EQUITY; HEALTH STATUS; HUMAN; KIDNEY CARCINOMA; LIFE EXPECTANCY; LIFE SUSTAINING TREATMENT; MONOTHERAPY; MULTIPLE MYELOMA; OCCUPATIONAL CANCER; PLEURA MESOTHELIOMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; RELIGION; REVIEW; SOCIAL DISCRIMINATION; SOCIAL STATUS; SOCIAL VALUE JUDGEMENT; TERMINAL CARE;

ADVISORY COMMITTEES; GREAT BRITAIN; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; JUDGMENT; QUALITY-ADJUSTED LIFE YEARS; SOCIAL VALUES;

EID: 84874837604     PISSN: 17441331     EISSN: 1744134X     Source Type: Journal    
DOI: 10.1017/S1744133112000096     Document Type: Review

References (42)

1. Avorn, J. (1984), 'Benefit and cost analysis in geriatric care-turning age discrimination into health policy', New England Journal of Medicine, 310: 129-130.
2. Baker, R., I. Bateman, C. Donaldson, M. Jones-Lee, E. Lancsar, G. Loomes, H. Mason, M. Odejar, J.L. Pinto-Prades, A. Robinson, M. Ryan, P. Shackley, R. Smith, R. Sugden and J. Wildman (2010), 'Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the social value of a QALY project', Health Technology Assessment, 14(27): 1-162.
3. Cookson, R., A. Tsuchiya and C. McCabe (2008), 'Public resource allocation and the rule of rescue', Journal of Medical Ethics, 34: 540-544.
4. Culyer, A. J. (1995), 'Need: the idea won't do-but we still need it', Social Science & Medicine, 40(6): 727-730.
5. Culyer, A. J. (2005), 'Involving stakeholders in healthcare decisions-the experience of the National Institute for Health and Clinical Excellence (NICE) in England and Wales', Healthcare Quarterly, 8: 56-60.
6. Culyer, A. J. and J. Lomas (2006), 'Deliberative processes and evidence-informed decisionmaking in health care-do they work and how might we know?', Evidence and Policy, 2: 357-371. (Pubitemid 44376997)
7. Daniels, N. (2000), 'Accountability for reasonableness', British Medical Journal, 321: 1300-1301.
8. Daniels, N. and J. E. Sabin (2008), 'Accountability for reasonableness: an update', British Medical Journal, 337: a1850.
9. Department of Health (2010), A New Value-Based Approach to the Pricing of Branded Medicines-a Consultation, London: Department of Health.
10. Dolan, P., R. Edlin, A. Tsuchiya, C. Armitage, A. Hukin, J. Brazier, R. Ibbotson, S. Bryan, D. Eiser and J.A. Olsen (2008), The Relative Societal Value of Health Gains to Different Beneficiaries: Final Report to NICE, London: National Institute for Health and Clinical Excellence.
11. Graham, H. and M. P. Kelly (2004), Health Inequalities: Concepts, Frameworks and Policy, London: Health Development Agency, Retrieved from http://www.nice.org.uk/page.aspx?o5502453.
12. Grimley-Evans, J. (1992), 'Quality of Life Assessments and Elderly People', in A. Hopkins (ed.), Measures of the Quality of Life and the Uses to Which such Measures may be put, London: Royal College of Physicians.
13. Harris, J. (2005), 'It's not NICE to discriminate', Journal of Medical Ethics, 31: 373-375. (Pubitemid 40945961)
14. Hoover, D. R., S. Crystal, R. Kumar, U. Sambamoorthi and J. C. Cantor (2002), 'Medical expenditures during the last year of life: findings from the 1992-1996 medicare current beneficiary survey', Health Services Research, 37: 1625-1642. (Pubitemid 36070257)
15. Jonsen, A. R. and S. Toulmin (1988), The Abuse of Casuistry: A History of Moral Reasoning, Berkeley: University of California Press.
16. Kennedy, I. (2009), Appraising the value of innovation and other benefits: a short study for NICE, London: NICE.
17. Littlejohns, P. and M. Rawlins (eds) (2009), Patients, the public and priorities in healthcare, Oxon: Radcliffe Publishing.
18. Longson, C. and P. Littlejohns (2009), Update Report on the Application of the 'End-of-Life' Supplementary Advice in Health Technology Appraisals, London: NICE.
19. McKie, J. and J. Richardson (2003), 'The rule of rescue', Social Science & Medicine, 56(12): 2407-2419. (Pubitemid 36555359)
20. National Health Service (NHS) (2005), Directions and Consolidating Directions to the National Institute for Health and Clinical Excellence 2005, London: NHS, Retrieved from http://www.nice.org.uk/niceMedia/pdf/ DirectionFromSecretaryOfState2005.pdf
21. National Institute for Health and Clinical Excellence (NICE) (2001), Guidance on the use of Riluzole (Rilutek) for the Treatment of Motor Neurone Disease, London: NICE.
22. NICE (2002), Guidance on the use of Trastuzumab for the Treatment of Advanced Breast Cancer, London: NICE.
23. NICE (2003), Guide to the Methods of Technology Appraisal, London: NICE.
24. NICE (2006a), Final Appraisal Determination: Pemetrexed Disodium for the Treatment of Malignant Pleural Mesothelioma, London: NICE.
25. NICE (2006b), Appraisal of Pemetrexed Disodium for the Treatment of Malignant Pleural Mesothelioma: Decision of the Panel, London: NICE.
26. NICE (2007), Omalizumab for Severe Persistent Allergic Asthma, London: NICE.
27. NICE (2008a), Social Value Judgements: Principles for the Development of NICE Guidance, 2nd edition, London: NICE.
28. NICE (2008b), Guide to the Methods of Technology Appraisal (second edition), London: NICE.
29. NICE (2008c), Alendronate, Etidronate, Risedronate, Raloxifene and Strontium Ranelate for the Primary Prevention of Osteoporotic Fragility Fractures in PostmenopausalWomen, London: NICE.
30. NICE (2008d), Pemetrexed for the Treatment of Malignant Pleural Mesothelioma, London: NICE.
31. NICE (2008e), Appraisal of Pemetrexed for the Treatment of Malignant Pleural Mesothelioma: Decision of the Panel, London: NICE.
32. NICE (2008f), Smoking Cessation Services in Primary Care, Pharmacies, Local Authorities andWorkplaces, Particularly for ManualWorking Groups, PregnantWomen and Hard to Reach Communities, London: NICE.
33. NICE (2009a), Methods for the Development of NICE Public Health Guidance (second edition), London: NICE.
34. NICE (2009b), Appraising Life-Extending, end of Life Treatments, London: NICE, Retrieved from http://www.nice.org.uk/media/E4A/79/ SupplementaryAdviceTACEoL. pdf [25 March 2011].
35. NICE (2009c), Bevacizumab (first-line), Sorafenib (first-and second-line), Sunitinib (secondline) and Temsirolimus (first-line) for the Treatment of Advanced and/or Metastatic renal Cell Carcinoma, London: NICE.
36. NICE (2010), Human Growth Hormone (Somatropin) for the Treatment of Growth Failure in Children, London: NICE.
37. Paulden, M. and A. J. Culyer (2010), 'Does Cost-effectiveness Analysis Discriminate Against Patients with Short Life Expectancy? Matters of Logic and Matters of Context'. CHE Research Paper 55. York: Centre for Health Economics, University of York.
38. Rawlins, M. (2004), Scientific and Social Value Judgements, London: NICE.
39. Rawlins, M., D. Barnett and A. Stevens (2010), 'Pharmacoeconomics: NICE's approach to decision-making', British Journal of Clinical Pharmacology, 70(3): 346-349.
40. Rawlins, M. D. and A. J. Culyer (2004), 'National institute for clinical excellence and its value judgements', British Medical Journal, 329: 224-227. (Pubitemid 39013284)
41. Shah, K. K. (2009), 'Severity of illness and priority setting in healthcare: a review of the literature', Health Policy, 93: 77-84.
42. Stevens, A., N. Doyle, P. Littlejohns and M. Docherty (2012), 'National institute for health and clinical excellence appraisal and ageism', Journal of Medical Ethics, doi: 10.1136/medethics-2011-100129.